Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$999,123
+$455,540 QoQ
Shares Held
833
+40.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3,147
of 4,605 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $2,738,678 across 11 Drug Manufacturers - General names. LLY ranks #1 (36.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
833 | $999,123 | |
| 2 | NVO |
Novo Nordisk A S
|
8,881 | $425,755 | |
| 3 | ABBV |
AbbVie Inc.
|
1,197 | $301,212 | |
| 4 | PFE |
Pfizer Inc
|
9,522 | $229,288 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,760 | $226,160 | |
| 6 | AMGN |
Amgen Inc
|
597 | $216,185 | |
| 7 | AZN |
Astrazeneca PLC
|
1,049 | $198,911 | |
| 8 | JNJ |
Johnson & Johnson
|
336 | $85,333 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $999,123 | 833 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $543,583 | 591 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $845,771 | 787 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $434,910 | 570 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $425,623 | 546 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $671,464 | 813 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,248,836 | 2,913 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $770,767 | 870 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $542,321 | 599 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $60,680 | 78 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,157,969 | 3,702 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,252,859 | 6,056 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,399,300 | 5,116 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,857 | 52 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $19,023 | 52 | Shares | Defined | 2023-02-13 | |
| 2022-06-30 | $3,911,834 | 12,065 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $34,364 | 120 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $43,090 | 156 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $36,043 | 156 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,280 | 145 | Shares | Defined | 2021-08-12 | |
| 2020-09-30 | $79,930 | 540 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $93,910 | 572 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $93,636 | 675 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||